Julie Jordan

Insider Reports History

Entity
Individual
Location
C/O Homology Medicines, Inc., One Patriots Park, Bedford, MA
Signature
/s/ Christine Mikail, as attorney-in-fact for Julie Jordan
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Julie Jordan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Neurogene Inc. Chief Medical Officer Common Stock 8.4K $142K $16.94 Mar 26, 2025 Direct
Homology Medicines, Inc. Chief Medical Officer Common Stock 7.5K $4.24K $0.57 Aug 3, 2023 Direct
Neurogene Inc. Chief Medical Officer Employee Stock Option (Right to buy) 50.3K Mar 26, 2025 Direct
Homology Medicines, Inc. Chief Medical Officer Restricted Stock Units 0 $1.15 Aug 3, 2023 Direct

Insider Reports Filed by Julie Jordan

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NGNE Neurogene Inc. Mar 26, 2025 2 $0 4 Mar 28, 2025 Chief Medical Officer
NGNE Neurogene Inc. Jan 16, 2024 1 $0 4 Jan 18, 2024 Chief Medical Officer
NGNE Neurogene Inc. Jan 16, 2024 0 $0 3 Jan 18, 2024 Chief Medical Officer
FIXX Homology Medicines, Inc. Aug 3, 2023 9 -$2.58K 4 Aug 7, 2023 Chief Medical Officer
FIXX Homology Medicines, Inc. Aug 2, 2023 3 -$130 4 Aug 4, 2023 Chief Medical Officer
FIXX Homology Medicines, Inc. Mar 7, 2023 0 $0 3 Mar 16, 2023 Chief Medical Officer